Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy

Abstract Aims Response to cardiac resynchronization therapy (CRT) is known to be associated with a number of clinical characteristics, including QRS duration and morphology, gender, height, and the aetiology of heart failure (HF). We assessed the relation of gender and baseline characteristics with...

Full description

Bibliographic Details
Main Authors: Bruce L. Wilkoff, David Birnie, Michael R. Gold, Ahmad S. Hersi, Sandra Jacobs, Bart Gerritse, Kengo Kusano, Christophe Leclercq, Wilfried Mullens, Gerasimos Filippatos
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12914
_version_ 1818734477752401920
author Bruce L. Wilkoff
David Birnie
Michael R. Gold
Ahmad S. Hersi
Sandra Jacobs
Bart Gerritse
Kengo Kusano
Christophe Leclercq
Wilfried Mullens
Gerasimos Filippatos
author_facet Bruce L. Wilkoff
David Birnie
Michael R. Gold
Ahmad S. Hersi
Sandra Jacobs
Bart Gerritse
Kengo Kusano
Christophe Leclercq
Wilfried Mullens
Gerasimos Filippatos
author_sort Bruce L. Wilkoff
collection DOAJ
description Abstract Aims Response to cardiac resynchronization therapy (CRT) is known to be associated with a number of clinical characteristics, including QRS duration and morphology, gender, height, and the aetiology of heart failure (HF). We assessed the relation of gender and baseline characteristics with QRS duration and Kansas City Cardiomyopathy Questionnaire. Methods and results AdaptResponse is a global randomized trial. The trial enrolled CRT‐indicated patients with New York Heart Association classes II–IV HF, left bundle branch block (QRS ≥ 140 ms in men, ≥130 ms in women), and baseline PR interval ≤200 ms. In total, 3620 patients were randomized, including 1569 women (43.3%) approaching the actual proportion of women in the HF population. Women were older and more often New York Heart Association class III or IV than men (55.6% vs. 48.7%), had less frequent ischaemic cardiomyopathy (21.2% vs. 39.5%), and had a 5.1 ms shorter QRS duration than men. Women were more often depressed (18.5% vs. 9.7%), had a significantly lower Kansas City Cardiomyopathy Questionnaire score, and had differences in medication prescriptions. Conclusions AdaptResponse is the largest randomized CRT trial and enrolled more women than any other landmark CRT trial. Women differed from men with regard to baseline characteristics and quality of life. Whether these differences translate into clinical outcome differences will be examined further in the AdaptResponse trial.
first_indexed 2024-12-18T00:05:59Z
format Article
id doaj.art-204dcf298dda4b32acfd52c9c1f7d5d7
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-18T00:05:59Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-204dcf298dda4b32acfd52c9c1f7d5d72022-12-21T21:27:47ZengWileyESC Heart Failure2055-58222020-10-01752972298210.1002/ehf2.12914Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapyBruce L. Wilkoff0David Birnie1Michael R. Gold2Ahmad S. Hersi3Sandra Jacobs4Bart Gerritse5Kengo Kusano6Christophe Leclercq7Wilfried Mullens8Gerasimos Filippatos9Cleveland Clinic Cleveland OH USAUniversity of Ottawa Heart Institute Ottawa Ontario CanadaDepartment of Cardiology Medical University of South Carolina Charleston SC USAFaculty of Medicine King Saud University Riyadh Saudi ArabiaMedtronic Bakken Research Center Maastricht The NetherlandsMedtronic Bakken Research Center Maastricht The NetherlandsNational Cerebral and Cardiovascular Center Osaka JapanDepartment of Cardiology University of Rennes Rennes FranceDepartment of Cardiology, Ziekenhuis Oost‐Limburg, Genk Belgium and Hasselt University Hasselt BelgiumSchool of Medicine National and Kapodistrian University of Athens Athens GreeceAbstract Aims Response to cardiac resynchronization therapy (CRT) is known to be associated with a number of clinical characteristics, including QRS duration and morphology, gender, height, and the aetiology of heart failure (HF). We assessed the relation of gender and baseline characteristics with QRS duration and Kansas City Cardiomyopathy Questionnaire. Methods and results AdaptResponse is a global randomized trial. The trial enrolled CRT‐indicated patients with New York Heart Association classes II–IV HF, left bundle branch block (QRS ≥ 140 ms in men, ≥130 ms in women), and baseline PR interval ≤200 ms. In total, 3620 patients were randomized, including 1569 women (43.3%) approaching the actual proportion of women in the HF population. Women were older and more often New York Heart Association class III or IV than men (55.6% vs. 48.7%), had less frequent ischaemic cardiomyopathy (21.2% vs. 39.5%), and had a 5.1 ms shorter QRS duration than men. Women were more often depressed (18.5% vs. 9.7%), had a significantly lower Kansas City Cardiomyopathy Questionnaire score, and had differences in medication prescriptions. Conclusions AdaptResponse is the largest randomized CRT trial and enrolled more women than any other landmark CRT trial. Women differed from men with regard to baseline characteristics and quality of life. Whether these differences translate into clinical outcome differences will be examined further in the AdaptResponse trial.https://doi.org/10.1002/ehf2.12914Cardiac resynchronization therapy outcomeLV pacingAV conductionLeft bundle branch blockGender differences in heart failureKansas City Cardiomyopathy Questionnaire
spellingShingle Bruce L. Wilkoff
David Birnie
Michael R. Gold
Ahmad S. Hersi
Sandra Jacobs
Bart Gerritse
Kengo Kusano
Christophe Leclercq
Wilfried Mullens
Gerasimos Filippatos
Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
ESC Heart Failure
Cardiac resynchronization therapy outcome
LV pacing
AV conduction
Left bundle branch block
Gender differences in heart failure
Kansas City Cardiomyopathy Questionnaire
title Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
title_full Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
title_fullStr Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
title_full_unstemmed Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
title_short Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
title_sort differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
topic Cardiac resynchronization therapy outcome
LV pacing
AV conduction
Left bundle branch block
Gender differences in heart failure
Kansas City Cardiomyopathy Questionnaire
url https://doi.org/10.1002/ehf2.12914
work_keys_str_mv AT brucelwilkoff differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT davidbirnie differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT michaelrgold differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT ahmadshersi differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT sandrajacobs differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT bartgerritse differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT kengokusano differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT christopheleclercq differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT wilfriedmullens differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy
AT gerasimosfilippatos differencesinclinicalcharacteristicsandreportedqualityoflifeofmenandwomenundergoingcardiacresynchronizationtherapy